Perspectives of Patients With Rheumatic Diseases in the Early Phase of COVID-19.

Anna S AntonyKathryn ConnellyThilinie De SilvaLaura EadesWilliam TillettSally AyoubEric F Morand

Published in: Arthritis care & research (2020)

Concerns regarding the risk of COVID-19 among patients taking antirheumatic drugs are common. Proactive dissemination of information is needed to address misconceptions related to medication risk, improve medication adherence, and minimize the risk of flares. Telehealth is acceptable to most patients during the COVID-19 pandemic.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
rheumatoid arthritis
peritoneal dialysis
health information
rheumatoid arthritis patients
respiratory syndrome coronavirus
patient reported outcomes
social media
disease activity
adverse drug